Business Services Industry
Board of Patent Appeals and Interferences Gives Luxtron Favorable Ruling on Ripple Technique Patent Claims; Administrative Patent Judge Confirms Luxtron as Developer of Non-Contact In-Situ Wafer Temperature Measurement Technique, Rejects Texas Instruments' Claim
Business Wire, Feb 12, 1997
SANTA CLARA, Calif.--(BUSINESS WIRE)--Feb. 12, 1997--Luxtron Corporation announced today that the U.S. Board of Patent Appeals and Interferences ruled in its favor on the action (Patent Interference No. 103,474) it brought for determination of the ownership of the invention of the non-contact wafer temperature method widely known as the "Ripple Technique."
The action resulted from Texas Instruments' claim of ownership of this method.
The ripple technique is used in single-wafer processing, to measure both temperature and emissivity of filmed wafers. It has been successfully applied in a number of single-wafer processing tools, including AG Associates' RTP tools. This in-situ pyrometric method uses the background light flicker -- or ripple -- to carry out its measurements.
Related Results
"It is Luxtron's ongoing policy to protect our intellectual property," stated Bob Goodman, president and CEO of Luxtron. "We are naturally gratified by the Board of Patent Appeals and Interferences' decision, and intend to actively continue this policy."
Luxtron has so far been granted five ripple technique patents, (U.S. No. 5,154,512, October 13, 1992; U.S. No. 5,166,080, November 24, 1992; U.S. No. 5,310,260, May 10, 1994; U.S. No. 5,318,362, June 7, 1994; and U.S. No. 5,460,728, February 13, 1996). It soon expects to be granted a sixth one.
Luxtron Corporation, founded in 1978 with headquarters and ISO 9001-certified manufacturing facilities located in Santa Clara, Calif., develops, manufactures and markets unique sensors and instrumentation, based on optical and heat flow technologies, for a wide range of industrial, medical, semiconductor, and R&D applications. Luxtron is a wholly owned subsidiary of the Fairey Group. Luxtron has four product lines including:
-- Luxtron brand fiberoptic temperature sensors and instruments using patented Fluoroptic(R) sensors, intrinsically safe and immune to EM interference (-200 C to 450 C).
-- Accufiber brand sapphire/fiberoptic sensors and instruments used for non-contact wafer and furnace temperature measurements based on the Plank equation and light emission technology ( 100 C to 4000 C).
-- Xinix brand semiconductor and LCD panel process controllers using non-contacting optical sensors in plasma (dry) etch, wet etch, resist develop and CMP processing equipment to determine precisely when a process or step is completed.
-- Transmet brand non-contact temperature systems, applied to moving objects in industrial processes such as wire and optical fiber production ( 10 C to 300 C).
You can visit the Luxtron Web site at http://www.luxtron.com .
CONTACT: Luxtron Corporation
Bob Goodman, 408/727-1600
or
The Benjamin Group Inc.
Alex Braun, 408/559-6090
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


